Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
LENZ Therapeutics, Inc. (NASDAQ: LENZ)
LENZ Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
218.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
351.50%
LENZ Stock Analysis
LENZ
PE Ratio:
LENZ
PEG Ratio:
Not Available
LENZ
Forward EPS Growth (12 month):
0.00%
LENZ
PS Ratio:
10.5
LENZ
PSG Ratio:
LENZ
Forward Revenue Growth (12 month):
238.90%
LENZ Articles
No data was found